We started Power when my dad was diagnosed with multiple myeloma, and I struggled to help him access the latest immunotherapy. Hopefully Power makes it simpler for you to explore promising new treatments, during what is probably a difficult time.
Trial Phase
Trial Status
Paid Participation
Clear All
Trial Details
Key Eligibility Criteria
714 Participants Needed
Trial Details
Key Eligibility Criteria
720 Participants Needed
Trial Details
Key Eligibility Criteria
898 Participants Needed
Trial Details
Key Eligibility Criteria
575 Participants Needed
Trial Details
Key Eligibility Criteria
640 Participants Needed
Trial Details
Key Eligibility Criteria
596 Participants Needed
Trial Details
Key Eligibility Criteria
75 Participants Needed
Trial Details
Key Eligibility Criteria
600 Participants Needed
Trial Details
Key Eligibility Criteria
1200 Participants Needed
Trial Details
Key Eligibility Criteria
1059 Participants Needed
Trial Details
Key Eligibility Criteria
285 Participants Needed
Trial Details
Key Eligibility Criteria
16 Participants Needed
Trial Details
Key Eligibility Criteria
30 Participants Needed
Trial Details
Key Eligibility Criteria
278 Participants Needed
Trial Details
Key Eligibility Criteria
2100 Participants Needed
Trial Details
Key Eligibility Criteria
24 Participants Needed
Trial Details
Key Eligibility Criteria
450 Participants Needed
Trial Details
Key Eligibility Criteria
315 Participants Needed
Trial Details
Key Eligibility Criteria
600 Participants Needed
Trial Details
Key Eligibility Criteria
300 Participants Needed
"I have dealt with voice and vocal fold issues related to paralysis for over 12 years. This problem has negatively impacted virtually every facet of my life. I am an otherwise healthy 48 year old married father of 3 living. My youngest daughter is 12 and has never heard my real voice. I am now having breathing issues related to the paralysis as well as trouble swallowing some liquids. In my research I have seen some recent trials focused on helping people like me."
"I've been struggling with ADHD and anxiety since I was 9 years old. I'm currently 30. I really don't like how numb the medications make me feel. And especially now, that I've lost my grandma and my aunt 8 days apart, my anxiety has been even worse. So I'm trying to find something new."
"My orthopedist recommended a half replacement of my right knee. I have had both hips replaced. Currently have arthritis in knee, shoulder, and thumb. I want to avoid surgery, and I'm open-minded about trying a trial before using surgery as a last resort."
"As a healthy volunteer, I like to participate in as many trials as I'm able to. It's a good way to help research and earn money."
"I changed my diet in 2020 and I’ve lost 95 pounds from my highest weight (283). I am 5’3”, female, and now 188. I still have a 33 BMI. I've been doing research on alternative approaches to continue my progress, which brought me here to consider clinical trials."
Trial Details
Key Eligibility Criteria
476 Participants Needed
Trial Details
Key Eligibility Criteria
325 Participants Needed
Trial Details
Key Eligibility Criteria
641 Participants Needed
Trial Details
Key Eligibility Criteria
723 Participants Needed
Trial Details
Key Eligibility Criteria
1000 Participants Needed
Trial Details
Key Eligibility Criteria
1633 Participants Needed
Trial Details
Key Eligibility Criteria
420 Participants Needed
Trial Details
Key Eligibility Criteria
400 Participants Needed
Trial Details
Key Eligibility Criteria
400 Participants Needed
Trial Details
Key Eligibility Criteria
230 Participants Needed
Know someone looking for new options?
Spread the word
Each trial will compensate patients a different amount, but $50-100 for each visit is a fairly common range for Phase 2–4 trials (Phase 1 trials often pay substantially more). Further, most trials will cover the costs of a travel to-and-from the clinic.
After a researcher reviews your profile, they may choose to invite you in to a screening appointment, where they'll determine if you meet 100% of the eligibility requirements. If you do, you'll be sorted into one of the treatment groups, and receive your study drug. For some trials, there is a chance you'll receive a placebo. Across Migraine trials 30% of clinical trials have a placebo. Typically, you'll be required to check-in with the clinic every month or so. The average trial length for Migraine is 12 months.
Not all studies recruit healthy volunteers: usually, Phase 1 studies do. Participating as a healthy volunteer means you will go to a research facility several times over a few days or weeks to receive a dose of either the test treatment or a "placebo," which is a harmless substance that helps researchers compare results. You will have routine tests during these visits, and you'll be compensated for your time and travel, with the number of appointments and details varying by study.
The phase of a trial reveals what stage the drug is in to get approval for a specific condition. Phase 1 trials are the trials to collect safety data in humans. Phase 2 trials are those where the drug has some data showing safety in humans, but where further human data is needed on drug effectiveness. Phase 3 trials are in the final step before approval. The drug already has data showing both safety and effectiveness. As a general rule, Phase 3 trials are more promising than Phase 2, and Phase 2 trials are more promising than phase 1.
Clinical trials are almost always free to participants, and so do not require insurance. The only exception here are trials focused on cancer, because only a small part of the typical treatment plan is actually experimental. For these cancer trials, participants typically need insurance to cover all the non-experimental components.
Most recently, we added Glycerol Tributyrate for MELAS Syndrome and Optic Neuropathy, Rimegepant + Zavegepant for Migraine and Zavegepant for Migraine to the Power online platform.
Migraine care has two parts: 1) fast-acting medicines for an attack, which range from simple pain relievers to triptans, newer CGRP blockers (ubrogepant, rimegepant), the ditan lasmiditan, ergotamine/DHE, and even handheld nerve-stimulation devices; and 2) preventive strategies taken regularly—beta-blockers, anti-seizure or antidepressant drugs, CGRP monoclonal-antibody injections, atogepant tablets, Botox, plus consistent sleep, exercise and trigger management—to cut down how often headaches occur. Doctors match these tools to your migraine frequency, other health conditions and side-effect risks, and will step up to preventive therapy if you still have about four or more disabling headache days per month.
Migraine starts with an inherited “hyper-excitable” brain network—particularly in the brain-stem and trigeminal pain pathways—that can be set off by waves of nerve activity (called cortical spreading depression) and the release of pain chemicals like CGRP. Hormone shifts, lack of sleep, certain foods, or stress don’t create the disease; they simply lower the threshold and provoke attacks in someone who already has this biological vulnerability. Knowing this helps you focus on both preventive medicines that calm those brain pathways and lifestyle steps that avoid personal triggers.
Chronic migraine means you suffer headaches on 15 or more days each month for at least three months, with at least eight of those days having typical migraine features; it is a long-term pattern, not a single marathon attack (that latter problem is called status migrainosus). The condition is usually tackled by limiting trigger factors and medication-overuse while starting a preventive treatment—such as daily oral drugs, periodic Botox injections, or the newer once-monthly CGRP antibody shots—under the guidance of a neurologist or headache specialist. Seek urgent care if any single attack lasts beyond 72 hours or suddenly feels different, as that could signal status migrainosus or another emergency.
Electrolyte drinks are useful mainly when a migraine is brought on by dehydration—replacing both water and minerals can shorten or stop those attacks. Research shows only magnesium (about 400–600 mg a day) has real preventive benefit; extra sodium or potassium hasn’t been proven helpful and can be risky if you have heart, kidney or blood-pressure issues. Aim for steady daily hydration, use an electrolyte solution after heavy sweating or illness, and check with your doctor before taking regular magnesium or high-salt products.
The “5 C’s” are five foods and drinks that some people notice can spark a migraine: cheese, chocolate, coffee, cola (or other caffeinated soft drinks), and citrus fruits. They are only possible triggers—each one bothers certain individuals because of ingredients like tyramine or caffeine—so the practical way to find out if they affect you is to log what you eat and when headaches start, then review that pattern with your healthcare provider before cutting anything out.
For most people migraines are worst in their 20s-40s and slowly ease after about age 50, particularly once the hormonal ups-and-downs of perimenopause settle. That said, attacks can flare at any age if triggers pile up—hormone shifts, stress, poor sleep, or frequent use of pain relievers—so a new or noticeably different headache pattern after 50 deserves a medical check-up to rule out other causes. Keeping a trigger diary, limiting acute medicines, and asking your clinician about modern preventives (from CGRP blockers to lifestyle coaching) can stop migraines from feeling “worse with age.”
Migraine isn’t one simple defect but a tangle of many factors—dozens of genes, changing hormones, brain-wave events like “cortical spreading depression,” and pain chemicals such as CGRP—so blocking a single switch can’t cure every patient without also risking side-effects. Instead, doctors manage it by combining quick-relief drugs (triptans, newer CGRP blockers) with preventives (CGRP antibodies, beta-blockers, Botox, nerve-stimulation devices) while researchers keep mapping the circuitry to design even more targeted fixes. In short: we can’t yet erase migraine for everyone, but understanding is growing fast and today’s tailored treatments already let many people live nearly attack-free.
“G-pants” is a nickname for “gepants,” a new group of oral (and one nasal-spray) migraine drugs—ubrogepant, rimegepant, atogepant and zavegepant—that block the CGRP receptor, a chemical switch that helps trigger migraine pain. Taken either at the start of an attack (ubrogepant, rimegepant, zavegepant) or once daily/every other day to cut the number of attacks (atogepant, rimegepant), they offer relief without the blood-vessel-tightening risk of older triptans; the most typical side-effects are mild nausea, fatigue or taste changes. Ask your doctor whether gepants fit your situation, especially if you have heart-disease risks or haven’t done well on triptans.
Think of it in two steps. 1) If a migraine has dragged on for 3-plus days, a headache specialist can “break” it with short-term measures such as a triptan or NSAID taken early, a brief oral steroid taper, or in clinic/ER infusions like dihydroergotamine, IV metoclopramide, or a newer “gepant” pill; these reset the attack without causing medication-overuse headache. 2) To keep it from becoming chronic again, you need daily prevention tailored to you—common options are onabotulinumtoxinA shots or once-monthly CGRP-antibody injections, strict trigger and sleep hygiene, and limiting pain pills to <10 days a month—reviewed every few months with a headache specialist.
Doctors use onabotulinumtoxinA, best known by the brand name Botox, to prevent chronic migraine—defined as at least 15 headache days a month—when standard preventive medicines haven’t helped. Every 12 weeks a neurologist injects tiny amounts into about 31 spots across the scalp, forehead, and neck; this can cut monthly headache days by roughly 7-9 days, with the most common side-effects being temporary neck pain or mild eyelid droop. Ask your headache specialist whether you meet the criteria and whether any other medical conditions or medications would make this treatment unsuitable for you.